| Mary Farrar, | |
|
755 S Beckham Ave, Tyler, TX 75701-1903 | |
| (903) 534-4684 | |
| Not Available |
| Full Name | Mary Farrar |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 755 S Beckham Ave, Tyler, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407439557 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 123086 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Farrar, 755 S Beckham Ave, Tyler, TX 75701-1903 Ph: (903) 534-4684 | Mary Farrar, 755 S Beckham Ave, Tyler, TX 75701-1903 Ph: (903) 534-4684 |
News Archive
PregLem, the Swiss specialty biopharmaceutical company focused on women's reproductive medicine, announces a world-wide, exclusive in licensing agreement for Bentamapimod, a novel, orally active, Jun Kinase Inhibitor from Merck Serono for an undisclosed amount. PregLem will develop the compound for the prevention of post-surgical abdominal adhesions and endometriosis in patients with tubal ligation or comparable effective contraception.
Countries are narrowing in on a "deal to speed up their response to the next flu pandemic by sharing virus samples in return for access to affordable vaccines," co-chairs of a WHO working group told reporters on Tuesday, Reuters reports.
If genes form the body's blueprint, then the layer of epigenetics decides which parts of the plan get built. Unfortunately, many cancers hijack epigenetics to modulate the expression of genes, thus promoting cancer growth and survival.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
As we develop, the company we keep may be increasingly influenced by our genes, according to a new study led by Virginia Commonwealth University researchers.
› Verified 8 days ago
Tiffany Williams, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9846 Hwy 31 E, Tyler, TX 75705 Phone: 903-592-8001 | |
Kimberly Mills, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9846 Hwy 31 E, Tyler, TX 75705 Phone: 903-592-8001 | |
Vongretshun Smith-gross, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9846 Hwy 31 E, Tyler, TX 75705 Phone: 903-525-3801 Fax: 903-525-3858 | |
Mary Craddock, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9846 Hwy 31 E, Tyler, TX 75705 Phone: 903-525-3995 Fax: 903-525-3858 | |
Vickie Denise Brown, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 755 S Beckham Ave, Tyler, TX 75701 Phone: 903-534-4684 | |
Pennye Sheridan, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 755 S Beckham Ave, Tyler, TX 75701 Phone: 903-534-4684 |